|
Number of participants with baseline 25(OH)D at level specified (%)
|
All infections
|
Infections seen in clinic
|
---|
Unadjusted
|
Adjusteda
|
Unadjusted
|
Adjusteda
|
---|
All persons
|
Placebo
|
16 (47.1)
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
0.83 (0.53, 1.31)
|
0.80 (0.50, 1.30)
|
0.86 (0.50, 1.50)
|
0.87 (0.52, 1.46)
|
Treatment
|
18 (52.9)
|
P = 0.42
|
P = 0.37
|
P = 0.60
|
P = 0.60
|
25(OH)D threshold (nmol/L)
|
≤40
|
Placebo
|
2 (50.0)
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
Treatment
|
2 (50.0)
|
0.56 (0.32, 0.96)b
|
0.41 (0.22, 0.78)b
|
0.27 (0.07, 1.00)b
|
0.26 (0.06, 1.17)
|
P = 0.036b
|
P = 0.007b
|
P = 0.050b
|
P = 0.079
|
≤50
|
Placebo
|
4 (50.0)
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
Treatment
|
4 (50.0)
|
0.61 (0.38, 0.98)b
|
0.68 (0.34, 1.34)
|
0.48 (0.18, 1.30)
|
0.57 (0.18, 1.78)
|
P = 0.043b
|
P = 0.27
|
P = 0.15
|
P = 0.34
|
≤60
|
Placebo
|
4 (40.0)
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
Treatment
|
6 (60.0)
|
0.86 (0.54, 1.35)
|
1.02 (0.60, 1.72)
|
0.66 (0.34, 1.30)
|
0.74 (0.36, 1.56)
|
P = 0.50
|
P = 0.95
|
P = 0.23
|
P = 0.43
|
≤70
|
Placebo
|
5 (29.4)
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
1.00 [reference]
|
Treatment
|
12 (70.6)
|
0.80 (0.51, 1.25)
|
0.82 (0.48, 1.41)
|
0.95 (0.46, 1.97)
|
0.85 (0.42, 1.70)
|
P = 0.33
|
P = 0.48
|
P = 0.89
|
P = 0.64
|
- Results are presented as HR (95% CI).
- 25(OH)D 25-hydroxyvitamin D, nmol/L nanomoles per litre.
- aAnalyses adjusted for age, sex, ever smoking and days per week engaging in vigorous physical activity.
- bStatistically significant.